Search research articles
Contact Us
Filters
Showing results (11-20 of 56) with videos related to
Page
of 6
Sort By:
Advances in Therapy
|
April 7, 2025
Baseline Characteristics and Treatment Patterns of Patients with Atopic Dermatitis Treated with Oral Systemic Therapies: An Interim Analysis of the AD-REAL Study
Matthias Augustin, Esther Serra-Baldrich, Julien Seneschal, et al.
Dermatology and Therapy
|
April 26, 2021
Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies
Timo Buhl, David Rosmarin, Esther Serra-Baldrich, et al.
Dermatology and Therapy
|
November 12, 2021
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective
Marjolein de Bruin-Weller, Joseph F Merola, Chih-Ho Hong, et al.
Dermatology Research and Practice
|
April 23, 2020
Consensus on the Clinical Approach to Moderate-to-Severe Atopic Dermatitis in Spain: A Delphi Survey
Joaquín Sastre, Esther Serra Baldrich, José Carlos Armario Hita, et al.
The Journal of Dermatological Treatment
|
April 18, 2022
Comorbidity identification and referral in atopic dermatitis: a consensus document
Javier Ortíz de Frutos, Gregorio Carretero, Raul de Lucas, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias
|
July 12, 2021
Managing urticaria in the emergency department: recommendations of a multidisciplinary expert panel
Juan Francisco Silvestre Salvador, Ana María Giménez-Arnau, Enrique Gómez de la Fuente, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
September 26, 2023
Pruritus and Pain Constitute the Main Negative Impact of Atopic Dermatitis® From the Patient's Perspective: A Systematic Review
José Carlos Armario-Hita, Jose Manuel Carrascosa, Ángeles Flórez, et al.
Dermatology (Basel, Switzerland)
|
July 2, 2025
Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials
Peter A Lio, David Rosmarin, Jose-Manuel Carrascosa, et al.
The Australasian Journal of Dermatology
|
December 7, 2023
Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis
Gemma Melé-Ninot, Laia Curto-Barredo, Montserrat Bonfill-Ortí, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 5, 2026
Quick assessment of quality-of-life in itch: An exploratory validation of the 5-item pruritus life quality
Claudia Zeidler, Simone Garcovich, Svetlana Bobko, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 56) with videos related to
Sort By:
Page
of 6
Advances in Therapy
|
April 7, 2025
Baseline Characteristics and Treatment Patterns of Patients with Atopic Dermatitis Treated with Oral Systemic Therapies: An Interim Analysis of the AD-REAL Study
Matthias Augustin, Esther Serra-Baldrich, Julien Seneschal, et al.
Dermatology and Therapy
|
April 26, 2021
Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies
Timo Buhl, David Rosmarin, Esther Serra-Baldrich, et al.
Dermatology and Therapy
|
November 12, 2021
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective
Marjolein de Bruin-Weller, Joseph F Merola, Chih-Ho Hong, et al.
Dermatology Research and Practice
|
April 23, 2020
Consensus on the Clinical Approach to Moderate-to-Severe Atopic Dermatitis in Spain: A Delphi Survey
Joaquín Sastre, Esther Serra Baldrich, José Carlos Armario Hita, et al.
The Journal of Dermatological Treatment
|
April 18, 2022
Comorbidity identification and referral in atopic dermatitis: a consensus document
Javier Ortíz de Frutos, Gregorio Carretero, Raul de Lucas, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias
|
July 12, 2021
Managing urticaria in the emergency department: recommendations of a multidisciplinary expert panel
Juan Francisco Silvestre Salvador, Ana María Giménez-Arnau, Enrique Gómez de la Fuente, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
September 26, 2023
Pruritus and Pain Constitute the Main Negative Impact of Atopic Dermatitis® From the Patient's Perspective: A Systematic Review
José Carlos Armario-Hita, Jose Manuel Carrascosa, Ángeles Flórez, et al.
Dermatology (Basel, Switzerland)
|
July 2, 2025
Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials
Peter A Lio, David Rosmarin, Jose-Manuel Carrascosa, et al.
The Australasian Journal of Dermatology
|
December 7, 2023
Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis
Gemma Melé-Ninot, Laia Curto-Barredo, Montserrat Bonfill-Ortí, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 5, 2026
Quick assessment of quality-of-life in itch: An exploratory validation of the 5-item pruritus life quality
Claudia Zeidler, Simone Garcovich, Svetlana Bobko, et al.
Page
of 6